Indrayani Biotech has appointed C.S. Shanmuga Sundar as its Company Secretary and Compliance Officer, effective September 9, 2026. The Board of Directors approved the appointment during a meeting held on the same date.

The hiring follows the resignation of Ms. Ramya Ravi, who ceased to hold the position effective June 3, 2026. Mr. Shanmuga Sundar holds membership number A58375 with the Institute of Company Secretaries of India.

Appointment Details

Mr. Shanmuga Sundar completed his Associate Company Secretary qualification on April 27, 2019. He brings experience in corporate secretarial functions, statutory compliance, and corporate governance. His most recent role was with Peiner Smag Machinery, where he served as Company Secretary overseeing secretarial and governance functions.

The company confirmed that Mr. Shanmuga Sundar is not related to any directors of the company. The appointment was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Indrayani Biotech has disclosed the resignation of its secretarial auditor, K. Ravichandran. The departure becomes effective from August 6, 2026.

The company informed the Bombay Stock Exchange on September 7, 2026, regarding the change in statutory personnel. Mr. Ravichandran cited personal reasons for stepping down from his role.

Regulatory Disclosure

The notification was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure aligns with Part A of Schedule III to the regulations and applicable SEBI circulars.

Mr. Ravichandran holds Membership No. ACS12838 and Certificate of Practice No. 3207. The filing includes a copy of his resignation letter and detailed disclosures as required by the listing norms.

Next Steps

The Audit Committee and the Board of Directors will consider the appointment of a new secretarial auditor to fill the vacancy. The company stated that the appointment will be made in due course and intimated to the exchanges accordingly.

Swaminathan Govindarajan, Whole-time Director, signed the disclosure letter.